Associate editor: Y.S. ChatzizisisPCSK9 inhibition in LDL cholesterol reduction: Genetics and therapeutic implications of very low plasma lipoprotein levels
Keywords: آپولیپوپروتئین; Proprotein convertase subtilisin/kexin type 9; Low-density lipoprotein cholesterol; Low-density lipoprotein receptor; Genetics; Apo; apolipoprotein; CHD; coronary heart disease; EGFA; epidermal growth factor-like repeat homology domain; ER; endoplasmic re